coil occluder ישראל - עברית - Ministry of Health

coil occluder

a.m.i. technologies, ltd. - רופא - ספירלה קפיצית לסגירת חיבור עורקי מולד בין אבי העורקים לעורק הריאה

Hemorrhage Occluder Pin ישראל - עברית - Ministry of Health

hemorrhage occluder pin

גאמידה בע"מ - רופא - עצירת דימום פנים אגני

דיספורט ישראל - עברית - Ministry of Health

דיספורט

medison pharma ltd - botulinum a toxin 500 u/vial - lyophilized powder for injection - botulinum toxin - dysport is indicated for the : treatment of dynamic equinus foot deformity due to spasticity in ambulant paediatric cerebral palsy patients two years of age or older ; spasmodic torticollis in adults ; blepharospasm in adults; hemifacial spasm in adults ; treatment of spasticity of the arm post stroke; axillary hyperhydrosis ; treatment of moderate to severe glabellar lines.

אימנד 150 מ"ג IV ישראל - עברית - Ministry of Health

אימנד 150 מ"ג iv

merck sharp & dohme israel ltd - fosaprepitant as fosaprepitant dimeglumine 150 mg - powder for solution for infusion - aprepitant - emend iv 150mg in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.

סרזים 200 יחידות ישראל - עברית - Ministry of Health

סרזים 200 יחידות

sanofi - aventis israel ltd - imiglucerase 200 u/vial - powder for solution for infusion - imiglucerase - for the long term enzyme replacement therapy for patients with a confirmed diagnosis of type 1 gaucher disease that results in one or more of the following conditions: - anemia , - thrombocytopenia , - bone disease , - hepatomegaly or splenomegaly.

פברזיים 5 מ"ג ישראל - עברית - Ministry of Health

פברזיים 5 מ"ג

sanofi - aventis israel ltd - agalsidase beta 5 mg/ml - powder for concentrate for infusion - agalsidase beta - long-term enzyme replacement therapy in patients with a confirmed diagnosis of fabry disease.